Molecular evolutionary analysis of cancer cell lines

Molecular Cancer Therapeutics

Volumn 9, Issue 2, 2010, Pages 279-291

  Zhang, Yan ^a   Italia, Michael J ^b   Auger, Kurt R ^b   Halsey, Wendy S ^b   Van Horn, Stephanie F ^b   Sathe, Ganesh M ^b   Magid Slav, Michal ^b   Brown, James R ^b   Holbrook, Joanna D ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; NUCLEOTIDE;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CLADISTICS; CODON; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HISTOLOGY; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR CLASSIFICATION; ALGORITHM; CLUSTER ANALYSIS; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; NEOPLASM; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; EVOLUTION, MOLECULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASMS; NUCLEOTIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 76749115787     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-09-0508     Document Type: Article

References (49)

1. Sjoblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314:268-74.
2. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-6.
3. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-12.
4. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-8.
5. Sjoblom T. Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes. Curr Opin Oncol 2008;20:66-71.
6. Ruhe JE, Streit S, Hart S, et al. Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Res 2007; 67:11368-76.
7. Greaves M. Darwinian medicine: a case for cancer. Nat Rev Cancer 2007;7:213-21.
8. Nishizuka S, Charboneau L, Young L, et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 2003;100:14229-34.
9. Shankavaram UT, Reinhold WC, Nishizuka S, et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 2007;6:820-32.
10. Lorenzi PL, Reinhold WC, Varma S, et al. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther 2009;8:713-24.
11. Suda K, Onozato R, Yatabe Y, Mitsudomi T. EGFR T790M mutation: a double role in lung cancer cell survival? J Thorac Oncol 2009;4:1-4.
12. Snead JL, O'Hare T, Eide CA, Deininger MW. New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided? Clin Lymphoma Myeloma 2008;8 Suppl 3:S107-17.
13. Baldauf SL, Roger AJ, Wenk-Siefert I, Doolittle WF. A kingdom-level phylogeny of eukaryotes based on combined protein data. Science 2000;290:972-7.
14. Brown JR, Douady CJ, Italia MJ, Marshall WE, Stanhope MJ. Universal trees based on large combined protein sequence data sets. Nat Genet 2001;28:281-5.
15. Bamford S, Dawson E, Forbes S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 2004;91:355-8.
16. Zwickl DJ. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion [dissertation]. Austin (TX): The University of Texas at Austin, 2006.
17. Lewis PO. A genetic algorithmfor maximum-likelihood phylogeny inference using nucleotide sequence data. Mol Biol Evol 1998;15:277-83.
18. Huelsenbeck JP, Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001;17:754-5.
19. Ronquist F, Huelsenbeck JP. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003;19:1572-4.
20. Page RD. TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996;12:357-8.
21. Huson DH, Richter DC, Rausch C, Dezulian T, Franz M, Rupp R. Dendroscope: an interactive viewer for large phylogenetic trees. BMC Bioinformatics 2007;8:460.
22. Fenstermacher D, Street C, McSherry T, Nayak V, Overby C, Feldman M. The Cancer Biomedical Informatics Grid (caBIG). Conf Proc IEEE Eng Med Biol Soc 2005;1:743-6.
23. Musumarra G, Barresi V, Condorelli DF, Fortuna CG, Scire S. Genome-based identification of diagnostic molecular markers for human lung carcinomas by PLS-DA. Comput Biol Chem 2005;29: 183-95.
24. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003;95:14-8.
25. Musumarra G, Barresi V, Condorelli DF, Scire S. A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics. Biol Chem 2003;384:321-7.
26. Perez-Enciso M, Tenenhaus M. Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet 2003;112:581-92.
27. Modlich O, Prisack HB, Munnes M, Audretsch W, Bojar H. Predictors of primary breast cancers responsiveness to preoperative epirubicin/ cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures. J Transl Med 2005;3:32.
28. Man MZ, Dyson G, Johnson K, Liao B. Evaluating methods for classifying expression data. J Biopharm Stat 2004;14:1065-84.
29. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
30. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007;356:319-50.
31. Yang Z, Nielsen R. Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Mol Biol Evol 2002;19:908-17.
32. Zhang J, Nielsen R, Yang Z. Evaluation of an improved branch-site likelihood method for detecting positive selection at the molecular level. Mol Biol Evol 2005;22:2472-9.
33. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 1997;13:555-6.
34. Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 2007;24:1586-91.
35. Anisimova M, Yang Z. Multiple hypothesis testing to detect lineages under positive selection that affects only a few sites. Mol Biol Evol 2007;24:1219-28.
36. Spencer SL, Gerety RA, Pienta KJ, Forrest S. Modeling somatic evolution in tumorigenesis. PLoS Comput Biol 2006;2:e108.
37. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A 2006;103: 18238-42.
38. Kuhner MK, Felsenstein J. A simulation comparison of phylogeny algorithms under equal and unequal evolutionary rates. Mol Biol Evol 1994;11:459-68.
39. Boyer D, Quintanilla R, Lee-Fruman KK. Regulation of catalytic activity of S6 kinase 2 during cell cycle. Mol Cell Biochem 2008;307:59-64.
40. Li F, Ling X. Survivin study: an update of "what is the next wave?" J Cell Physiol 2006;208:476-86.
41. Beerenwinkel N, Antal T, Dingli D, et al. Genetic progression and the waiting time to cancer. PLoS Comput Biol 2007;3:e225.
42. Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007;446:153-8.
43. Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 2006;108:638-44.
44. Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-34.
45. van HD, Mooijaart SP, Beekman M, et al. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 2005;40:11-5.
46. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer 2009;9:95-107.
47. Nozawa M, Suzuki Y, Nei M. Reliabilities of identifying positive selection by the branch-site and the site-prediction methods. Proc Natl Acad Sci U S A 2009;106:6700-5.
48. Ragan MA. Matrix representation in reconstructing phylogenetic relationships among the eukaryotes. Biosystems 1992;28:47-55.
49. Varley KE, Mitra RD. Nested Patch PCR enables highly multiplexed mutation discovery in candidate genes. Genome Res 2008;18: 1844-50.